Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€3.71
17.03.24
17.03.24
€5.00
31.01.26
31.01.26
-2.70%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€8.01
05.09.22
05.09.22
-
05.10.26
05.10.26
-57.57%
11.03.24
11.03.24
Probably not worthwhile Investment
Cellectis Nom.
Start price
Target price
Perf. (%)
€1.26
16.10.23
16.10.23
-
16.10.24
16.10.24
95.87%
19.01.24
19.01.24
Risky Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€1.51
27.11.23
27.11.23
-
27.11.24
27.11.24
4.25%
11.12.23
11.12.23
Probably not worthwhile Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.10
01.11.23
01.11.23
€2.50
01.11.24
01.11.24
-25.24%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year
Cellectis Nom.
Start price
Target price
Perf. (%)
€1.96
01.11.23
01.11.23
€1.00
01.11.24
01.11.24
20.31%
11.11.23
11.11.23
Good culture
Below average Management
Few uniques
Probably not worthwhile Investment
Cellectis Nom.
Start price
Target price
Perf. (%)
€2.39
01.11.23
01.11.23
-
01.11.24
01.11.24
-1.42%
10.11.23
10.11.23
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.81
24.12.22
24.12.22
-
24.12.23
24.12.23
-25.37%
01.11.23
01.11.23
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€6.02
27.10.22
27.10.22
-
27.10.23
27.10.23
-42.03%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Avadel Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€12.30
19.07.23
19.07.23
-
19.08.23
19.08.23
-8.13%
20.08.23
20.08.23
Cellectis Nom.
Start price
Target price
Perf. (%)
€3.52
07.08.22
07.08.22
€3.80
07.08.23
07.08.23
-52.13%
08.08.23
08.08.23
Could be worthwhile Investment >10% per year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.10
04.08.22
04.08.22
-
04.08.23
04.08.23
81.32%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€9.82
21.07.22
21.07.22
-
21.07.23
21.07.23
-30.16%
22.07.23
22.07.23
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition